INS and type 2 diabetes mellitus: This treatment protects the liver against hepatic damage through the inhibition of endoplasmic reticulum stress in fructose-fed rats [58] and has anti-diabetes effects through ameliorating insulin resistance via the hepatic HIF-insulin signaling pathway in type-2 diabetic rats [59].